Inhaled corticosteroid therapy and risk of hospitalization with pneumonia: a population-based case-control study from Denmark Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009
Use of a national registry to assess palivizumab use Source: Annual Congress 2008 - Paediatric respiratory epidemiology II: air pollution studies and infectious disease epidemiology Year: 2008
Costs of treatment of hospitalised community-acquired pneumonia from the hospitals’ perspective – a prospective study comparing moxifloxacin with other antibiotic treatment alternatives Source: Eur Respir J 2004; 24: Suppl. 48, 185s Year: 2004
Immunotherapy as a preventive treatment for new onset asthma? A hospital-based retrospective cohort study Source: Eur Respir J 2005; 26: Suppl. 49, 134s Year: 2005
The impact of adherence to guidelines for hospitalized community-acquired pneumonia on health outcomes and mortality: A retrospective cohort study Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015
Time on therapy and concomitant medication use of mepolizumab in Canada: a retrospective cohort study Source: ERJ Open Res, 7 (1) 00778-2020; 10.1183/23120541.00778-2020 Year: 2021
GRACE-01 Genomics to combat resistance against antibiotics in community-acquired LRTI in Europe – a multicentre, observational cohort study of cough/LRTI in primary care Source: Annual Congress 2007 - Clinical trial: antibiotic use in the community Year: 2007
Effectiveness of treatments for severe sepsis: a prospective multicentre observational study in Spanish ICUs Source: Annual Congress 2009 - Severe sepsis and multiple organ failure Year: 2009
Antibiotic use in children and youths with asthma: a population-based case-control study Source: ERJ Open Res, 7 (1) 00944-2020; 10.1183/23120541.00944-2020 Year: 2021
Real-life effectiveness of omalizumab in difficult-to-treat versus severe asthma: a national cohort study in Belgium Source: ERJ Open Res, 5 (4) 00253-2018; 10.1183/23120541.00253-2018 Year: 2019
Cost-effectiveness of antibiotics for COPD management: observational analysis using CPRD data Source: ERJ Open Res, 3 (2) 00085-2016; 10.1183/23120541.00085-2016 Year: 2017
Guidelines of tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study Source: Eur Respir J 2001; 18: 369-375 Year: 2001
Risk for asthma following pneumonia in infancy – a nationwide register-based cohort study with family design Source: Virtual Congress 2020 – Different aspects of paediatric viral and bacterial lung infections Year: 2020
Early Rehospitalizations for Pneumonia: Incidence and Predictors in an Italian population-based cohort study Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019
Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study Source: Eur Respir J, 56 (4) 2001935; 10.1183/13993003.01935-2020 Year: 2020
Long-acting bronchodilator initiation in COPD and cardio-pulmonary risks: A population-based comparative effectiveness study Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016
Efficacy of immunotherapy with ribomunyl in children with recurrent respiratory infections: results of 3-year prospective study Source: Eur Respir J 2002; 20: Suppl. 38, 338s Year: 2002
Outcome of failed empirical antibiotic therapy on the mortality of elderly patients with hospitalized pneumonia: A propensity score-based analysis Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013
Characteristics and treatment regimens across ERS SHARP severe asthma registries Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases Year: 2019